131 related articles for article (PubMed ID: 20726051)
1. RhoGTPases and Rho-effectors in hepatocellular carcinoma metastasis: ROCK N'Rho move it.
Wong CC; Wong CM; Au SL; Ng IO
Liver Int; 2010 May; 30(5):642-56. PubMed ID: 20726051
[TBL] [Abstract][Full Text] [Related]
2. RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway.
Ma W; Wong CC; Tung EK; Wong CM; Ng IO
Hepatology; 2013 Jan; 57(1):152-61. PubMed ID: 22829315
[TBL] [Abstract][Full Text] [Related]
3. Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion.
Wong CC; Wong CM; Tung EK; Man K; Ng IO
Hepatology; 2009 May; 49(5):1583-94. PubMed ID: 19205033
[TBL] [Abstract][Full Text] [Related]
4. Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.
Wong CC; Wong CM; Ko FC; Chan LK; Ching YP; Yam JW; Ng IO
PLoS One; 2008 Jul; 3(7):e2779. PubMed ID: 18648664
[TBL] [Abstract][Full Text] [Related]
5. ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma.
Chen J; Xia H; Zhang X; Karthik S; Pratap SV; Ooi LL; Hong W; Hui KM
J Hepatol; 2015 Jun; 62(6):1287-95. PubMed ID: 25617497
[TBL] [Abstract][Full Text] [Related]
6. MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis.
Wong CM; Wei L; Au SL; Fan DN; Zhou Y; Tsang FH; Law CT; Lee JM; He X; Shi J; Wong CC; Ng IO
Oncotarget; 2015 May; 6(15):13658-70. PubMed ID: 25909223
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.
Wang H; Wang B; Liao Q; An H; Li W; Jin X; Cui S; Zhao L
FEBS Lett; 2014 Jan; 588(3):503-8. PubMed ID: 24374343
[TBL] [Abstract][Full Text] [Related]
8. SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.
Zhang YL; Li Q; Yang XM; Fang F; Li J; Wang YH; Yang Q; Zhu L; Nie HZ; Zhang XL; Feng MX; Jiang SH; Tian GA; Hu LP; Lee HY; Lee SJ; Xia Q; Zhang ZG
Cancer Res; 2018 May; 78(9):2305-2317. PubMed ID: 29440144
[TBL] [Abstract][Full Text] [Related]
9. Rho/ROCK signaling in motility and metastasis of gastric cancer.
Matsuoka T; Yashiro M
World J Gastroenterol; 2014 Oct; 20(38):13756-66. PubMed ID: 25320513
[TBL] [Abstract][Full Text] [Related]
10. Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma.
Genda T; Sakamoto M; Ichida T; Asakura H; Kojiro M; Narumiya S; Hirohashi S
Hepatology; 1999 Oct; 30(4):1027-36. PubMed ID: 10498656
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-148b targets Rho-associated protein kinase 1 to inhibit cell proliferation, migration and invasion in hepatocellular carcinoma.
Chen X; Bo L; Lu W; Zhou G; Chen Q
Mol Med Rep; 2016 Jan; 13(1):477-82. PubMed ID: 26530325
[TBL] [Abstract][Full Text] [Related]
12. Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation.
Huang D; Du X; Yuan R; Chen L; Liu T; Wen C; Huang M; Li M; Hao L; Shao J
Biochem Biophys Res Commun; 2014 Oct; 453(1):49-56. PubMed ID: 25251472
[TBL] [Abstract][Full Text] [Related]
13. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
14. MiR-506 suppresses cell proliferation and tumor growth by targeting Rho-associated protein kinase 1 in hepatocellular carcinoma.
Deng Q; Xie L; Li H
Biochem Biophys Res Commun; 2015 Nov; 467(4):921-7. PubMed ID: 26474697
[TBL] [Abstract][Full Text] [Related]
15. Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway.
Chen X; Zhang S; Wang Z; Wang F; Cao X; Wu Q; Zhao C; Ma H; Ye F; Wang H; Fang Z
J Exp Clin Cancer Res; 2018 Jun; 37(1):128. PubMed ID: 29954442
[TBL] [Abstract][Full Text] [Related]
16. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
[TBL] [Abstract][Full Text] [Related]
17. RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma.
Ma W; Sze KM; Chan LK; Lee JM; Wei LL; Wong CM; Lee TK; Wong CC; Ng IO
Oncotarget; 2016 Jul; 7(27):41445-41459. PubMed ID: 27213590
[TBL] [Abstract][Full Text] [Related]
18. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
[TBL] [Abstract][Full Text] [Related]
19. Dihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinoma.
Zhu WP; Liu ZY; Zhao YM; He XG; Pan Q; Zhang N; Zhou JM; Wang LR; Wang M; Zhan DH; Ma DN; Wang L
Cell Death Dis; 2018 Jan; 9(2):69. PubMed ID: 29358721
[TBL] [Abstract][Full Text] [Related]
20. Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma.
Tao X; Zuo Q; Ruan H; Wang H; Jin H; Cheng Z; Lv Y; Qin W; Wang C
Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):263-276. PubMed ID: 30883650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]